Medical Oncologist
CION Cancer Clinics
Clinical trials for colon cancer in India: how they work and how to find one | CION Cancer Clinics
Clinical trials for colon cancer do run in India, mostly at large cancer centres, but fewer than in the West and only a few are open at any one time. A trial can offer a new treatment under close watch, yet nobody knows in advance whether the new option works better. This page explains how trials work, who tends to qualify, what to ask before signing and how to find one. At CION Cancer Clinics, a multidisciplinary team plans colon cancer treatment for your stage, from surgery to chemotherapy and follow-up.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Are there clinical trials for colon cancer in India?
- What kinds of colon cancer trials might be open?
- How do you find and join a trial in India?
- The words you will meet, in plain language
- Are trial patients treated like guinea pigs?
- What this page cannot tell you
- Common questions about colon cancer trials
The short answer
Are there clinical trials for colon cancer in India?
Yes, but fewer than in the West, and only a handful are usually open to new patients at any one time. Most run at large cancer centres and medical colleges, and each one takes only people at a particular stage with particular test results. Finding one that fits you is possible, but it takes some searching and an oncologist who can read the entry rules with you.
What a trial actually is
A clinical trial is a carefully planned study that tests a new treatment, or a new way of using an old one, in people who agree to take part. It answers a question that doctors genuinely do not yet know the answer to. That uncertainty is the whole point. If the answer were already known, there would be no trial.
Why it matters even if you never join one
Almost every treatment used for colon cancer today, from the chemotherapy given after surgery to the drugs matched to gene changes, became standard because of trials. Asking about them is a normal question at any stage, not a sign that things are going badly.
A trial is an option to discuss, never an obligation and never a shortcut.What you may come across
What kinds of colon cancer trials might be open?
Trials cluster around the questions oncologists are still working on. These are the kinds you are most likely to see listed, not a promise that one is open near you.
New drugs for advanced disease
The largest group. They test new medicines in people whose cancer has spread and has stopped responding to standard treatment, usually after two or more lines of treatment.
Drugs matched to a gene change
Some trials only take tumours with a specific change, such as KRAS G12C, BRAF or HER2. Your biopsy report decides whether you can even be considered, which is why full marker testing matters.
Smarter decisions after surgery
These ask who truly needs chemotherapy after an operation and for how long, sometimes using a blood test for tumour DNA called ctDNA. The aim is to spare people treatment they do not need.
Supportive care and daily life
Trials of diet, exercise, nerve protection or ways to ease side effects. They carry less risk and are open to more people, including those with early disease.
These rarely make headlines but are often the easiest to join.Not sure whether this applies to you?
Ask an oncologistFrom question to consent
How do you find and join a trial in India?
Ask your oncologist first
Your treating team knows your stage, your markers and what standard treatment still has to offer. They can tell you whether a trial makes sense now, later, or not at all.
Search the national registry
Every trial in India must be listed on the Clinical Trials Registry of India (CTRI), a public website run under the ICMR. Search for colorectal cancer and note which trials are recruiting, where, and the contact named for each.
The screening visit
The trial team checks your reports, scans and blood tests against its entry rules. Many people are found not to qualify at this stage, which says nothing about how well they will do on standard treatment.
Consent, in your own language
You receive a written information sheet and consent form, which you can ask for in Telugu. Take it home, read it with family and ask every question before you sign. Only then does treatment on the trial begin.
In the trial papers
The words you will meet, in plain language
- Phase one, two and three
- Phase one finds a safe dose in a small group. Phase two checks whether the drug works on one cancer. Phase three compares it with standard treatment in many people.
- Randomised
- A computer decides which group you join. Neither you nor your doctor chooses, which keeps the comparison fair.
- Placebo
- A dummy medicine with no active drug. In cancer trials it is normally added on top of standard treatment, not given instead of it.
- Eligibility criteria
- The entry rules on stage, markers, blood counts, organ function and past treatment. They protect you as much as the study.
- Ethics committee
- An independent group of doctors, lawyers and lay members who must approve a trial before it starts and keep watching it while it runs.
- Sponsor
- The company or institution that pays for and organises the trial, usually supplying the trial medicine itself.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Are trial patients treated like guinea pigs?
"People in trials are just guinea pigs."
Indian rules require ethics committee approval, regulator permission for new drugs, informed consent and medical care with compensation if the trial causes harm. Trial patients are often watched more closely than anyone else in the clinic.
"In a trial you might get no treatment at all."
In cancer trials, a dummy pill is very rarely given in place of treatment known to work. Most trials compare a new option with the current standard, so everyone receives proper treatment.
"Trials are only for people who have run out of options."
Many are, but some are designed for people just after surgery or starting first treatment. Asking early widens the choice, because some trials only accept people who have not yet had a particular drug.
"A new drug in a trial must be better than the old one."
Nobody knows that yet, which is why the trial exists. Some new drugs turn out better, some the same, and some worse or more toxic. Join for the right reasons, with honest expectations.
Being straight with you
What this page cannot tell you
It cannot tell you which trials are open today. Trials open and close every month, and any list printed here would be out of date by the time you read it. The registry and your oncologist are the only reliable sources.
Who this does not apply to
Most people with colon cancer that has not spread are treated with well-tested surgery and chemotherapy, and do not need a trial to receive good care. Rectal cancer trials are separate, because the treatment path differs; start from the rectal cancer pages instead. People who are very unwell are usually not eligible, which protects them from extra hospital visits.
Where CION fits
CION's medical oncologists can look at a trial you have found, check whether you are likely to meet its entry rules and talk the consent form through with you. Treatment on the trial happens at the hospital running it. If you would rather stay on standard treatment, that is a sound choice too.
Never pay anyone to get you into a trial. A genuine trial does not charge a joining fee.Questions we are asked
Common questions about colon cancer trials
Can CION help me find a trial?
CION's oncologists can review a trial you have found, or look for ones that might match your stage and test results, and talk you through the consent document. The trial itself is run by the hospital or research centre named on the registry, and treatment happens there.
Do I have to pay to be in a trial?
The sponsor usually supplies the trial medicine and pays for tests the trial requires. Standard treatment given alongside, travel and stays may still cost you. Ask for a written list of what is covered before you sign, and keep a copy.
Can I leave a trial once I have joined?
Yes, at any time, and you do not have to give a reason. Leaving does not cost you your right to standard treatment. Tell the trial team first, because they will want to arrange your follow-up and stop the trial medicine safely.
How do I know a trial is genuine?
A genuine Indian trial is registered on CTRI, has ethics committee approval and gives you a written consent document with a named doctor and contact details. Be wary of anyone who asks for money to join or promises that the new drug will work.
Am I too old or too unwell for a trial?
Each trial sets rules on blood counts, kidney and liver function and how active you are day to day. Some older people qualify easily, while some younger people do not. Only a screening visit with the trial team can answer it for you.
Are there immunotherapy trials for colon cancer?
Some trials test immunotherapy, often in cancers that are not MSI-high, where standard immunotherapy rarely helps. For MSI-high cancer, immunotherapy is already an established option outside trials, so ask your oncologist about that first.
Is it worth travelling to another city for a trial?
Sometimes, especially if the trial tests a drug matched to a gene change your tumour carries. Count the visits, the length of the study and who will look after you between visits before deciding. Your oncologist can help you weigh it up honestly.
What should I bring when asking about trials?
Biopsy and surgery reports, the latest scans with their reports, MMR or MSI, RAS and BRAF results, and a list of every treatment you have had with dates. Trial teams decide eligibility from these papers, so a complete file saves a great deal of time.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Colon Cancer Treatment
- American Cancer Society — Colorectal Cancer Treatment
- ESMO — Colorectal Cancer: A Guide for Patients
- Cancer Research UK — Treatment for bowel (colorectal) cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
First-line, second-line and third-line treatmentWhere trials usually fit in advanced diseaseWhen treatment stops workingThe point at which many people first ask about trialsGetting a second opinion on a treatment planA second view before choosing between a trial and standard careQuestions to ask before starting treatmentA checklist that works for trial teams too
Talk to us
Found a trial and not sure it suits you?
Send us the trial details with your reports, and an oncologist will tell you honestly whether you are likely to qualify and what to ask. One helpline serves every CION centre.